Target intelligence / Profile preview

Collagen biosynthesis (extracellular matrix)

Molecular classification: Other (biological process), Enzyme (the process involves several enzymes, including lysyl oxidase, prolyl hydroxylase, and procollagen peptidases)

Overview

Collagen biosynthesis in the extracellular matrix is a tightly regulated process involving the transcription and translation of collagen genes, post-translational modifications (hydroxylation, glycosylation), and assembly into triple helices and fibrils. This process is crucial for the structural integrity and mechanical properties of tissues. Regulation involves multiple growth factors (especially TGF-β), enzymes (lysyl oxidase, matrix metalloproteinases), and interactions with other ECM proteins (fibronectin, proteoglycans). Aberrations in collagen synthesis or ECM remodeling contribute to pathologies like fibrosis, cancer progression, and connective tissue diseases.

Other names: Collagen productionCollagen depositionCollagen formation

Mechanism of action

Inhibition or modulation of TGF-β signaling (reduces collagen synthesis); Inhibition of lysyl oxidase (blocks crosslinking of collagen fibers); Activation of matrix metalloproteinases (MMPs, enhances collagen degradation)

Biological functions

Extracellular matrix formationTissue repairCell migration and anchorageCell proliferation and differentiation (via matrix signaling)Mechanical scaffold for organs and tissues

Disease associations

Fibrosis (excessive deposition)Cancer (altered ECM stiffness, tumor progression)Skin disorders (e.g., scarring, chronic wounds)Genetic connective tissue diseases (e.g., osteogenesis imperfecta, Ehlers-Danlos syndrome)Cardiovascular disease (vascular remodeling)Inflammation

Safety considerations

Excess inhibition may lead to poor wound healing or tissue weaknessExcessive stimulation or decreased degradation may cause fibrosis/stiffeningSystemic modulation of collagen synthesis could affect multiple organs

Interacting drugs

Pirfenidone (antifibrotic, indirectly modulates collagen synthesis)

3 more in the full profile.

Biomarkers

Procollagen type I N-terminal propeptide (PINP)Procollagen type III N-terminal propeptide (PIIINP)Mature collagen peptides in blood or tissues

Beyond the preview

Go deeper on Collagen biosynthesis (extracellular matrix).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen biosynthesis (extracellular matrix).

Explore the full profile